Related Experiment Video
Updated: Mar 29, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Deterministic direct reprogramming of somatic cells to pluripotency
Yoach Rais1, Asaf Zviran, Shay Geula
1The Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.
Abstract:
Somatic cells can be inefficiently and stochastically reprogrammed into induced pluripotent stem (iPS) cells by exogenous expression of Oct4 (also called Pou5f1), Sox2, Klf4 and Myc (hereafter referred to as OSKM). The nature of the predominant rate-limiting barrier(s) preventing the majority of cells to successfully and synchronously reprogram remains to be defined. Here we show that depleting Mbd3, a core member of the Mbd3/NuRD (nucleosome remodelling and deacetylation) repressor complex, together with OSKM transduction and reprogramming in naive pluripotency promoting conditions, result in deterministic and synchronized iPS cell reprogramming (near 100% efficiency within seven days from mouse and human cells). Our findings uncover a dichotomous molecular function for the reprogramming factors, serving to reactivate endogenous pluripotency networks while simultaneously directly recruiting the Mbd3/NuRD repressor complex that potently restrains the reactivation of OSKM downstream target genes. Subsequently, the latter interactions, which are largely depleted during early pre-implantation development in vivo, lead to a stochastic and protracted reprogramming trajectory towards pluripotency in vitro. The deterministic reprogramming approach devised here offers a novel platform for the dissection of molecular dynamics leading to establishing pluripotency at unprecedented flexibility and resolution.
Insights
Reprogramming somatic cells into induced pluripotent stem (iPS) cells is typically inefficient. Depleting Mbd3 enhances Oct4, Sox2, Klf4, and Myc (OSKM) reprogramming to near 100% efficiency, creating a deterministic and synchronized process.
Area of Science:
- Stem cell biology
- Epigenetics
- Molecular reprogramming
Background:
- Somatic cell reprogramming into induced pluripotent stem (iPS) cells using Oct4, Sox2, Klf4, and Myc (OSKM) is often inefficient and stochastic.
- The primary barriers to efficient and synchronous reprogramming remain largely undefined.
Purpose of the Study:
- To investigate the rate-limiting factors in somatic cell reprogramming.
- To develop a method for deterministic and synchronized iPS cell generation.
Main Methods:
- Exogenous expression of OSKM factors in somatic cells.
- Depletion of Mbd3, a component of the Mbd3/NuRD repressor complex.
- Reprogramming under naive pluripotency-promoting conditions.
Main Results:
- Depleting Mbd3 alongside OSKM transduction resulted in deterministic and synchronized iPS cell reprogramming with near 100% efficiency within seven days.
- Identified a dichotomous function of reprogramming factors: reactivating pluripotency networks and recruiting the Mbd3/NuRD complex to restrain target gene reactivation.
- Demonstrated that Mbd3/NuRD complex interactions, reduced during early development, contribute to the stochastic nature of in vitro reprogramming.
Conclusions:
- Mbd3 acts as a key repressor limiting the efficiency and synchronicity of OSKM-mediated reprogramming.
- The developed deterministic reprogramming approach provides a powerful platform for studying pluripotency establishment.
- Understanding the role of Mbd3/NuRD offers new insights into controlling cellular reprogramming dynamics.
More Related Videos
10:52Isolation of Adult Human Dermal Fibroblasts from Abdominal Skin and Generation of Induced Pluripotent Stem Cells Using a Non-Integrating Method
Published on: January 20, 2020
12:12In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
Published on: December 17, 2013
Related Concept Videos
Somatic to iPS Cell Reprogramming
Methods of Nuclear Reprogramming
Introduction to Nuclear Reprogramming
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells